<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/885DF811-29D2-42F7-AB4C-5857ED774495"><gtr:id>885DF811-29D2-42F7-AB4C-5857ED774495</gtr:id><gtr:name>Mbale Regional Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1CD49681-075D-4AB9-A644-ED328E7C8D3A"><gtr:id>1CD49681-075D-4AB9-A644-ED328E7C8D3A</gtr:id><gtr:name>Malaria Consortium Africa, Kampala</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/ABE644D6-BBB8-44F3-96AA-6F49F0964577"><gtr:id>ABE644D6-BBB8-44F3-96AA-6F49F0964577</gtr:id><gtr:name>KEMRI-Wellcome Trust Research Programme</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/885DF811-29D2-42F7-AB4C-5857ED774495"><gtr:id>885DF811-29D2-42F7-AB4C-5857ED774495</gtr:id><gtr:name>Mbale Regional Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1CD49681-075D-4AB9-A644-ED328E7C8D3A"><gtr:id>1CD49681-075D-4AB9-A644-ED328E7C8D3A</gtr:id><gtr:name>Malaria Consortium Africa, Kampala</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/ABE644D6-BBB8-44F3-96AA-6F49F0964577"><gtr:id>ABE644D6-BBB8-44F3-96AA-6F49F0964577</gtr:id><gtr:name>KEMRI-Wellcome Trust Research Programme</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5C8F1E89-FCDA-449D-9EAE-453C6C0B89A7"><gtr:id>5C8F1E89-FCDA-449D-9EAE-453C6C0B89A7</gtr:id><gtr:firstName>Trudie</gtr:firstName><gtr:surname>Lang</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B647A0AA-957F-4F2D-9658-94949E57E1BE"><gtr:id>B647A0AA-957F-4F2D-9658-94949E57E1BE</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:surname>Kiguli</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7E881B00-0772-4A4B-907F-71861A82EDB2"><gtr:id>7E881B00-0772-4A4B-907F-71861A82EDB2</gtr:id><gtr:firstName>Hugh</gtr:firstName><gtr:surname>Reyburn</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/86F8EE81-4F1B-447D-A0DF-9B291124FF81"><gtr:id>86F8EE81-4F1B-447D-A0DF-9B291124FF81</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Levin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/58B69503-B9E3-43E3-AEB2-82D521E4C95E"><gtr:id>58B69503-B9E3-43E3-AEB2-82D521E4C95E</gtr:id><gtr:firstName>Diana</gtr:firstName><gtr:surname>Gibb</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CD4AB659-6AEB-45EE-B1E8-9EA381471181"><gtr:id>CD4AB659-6AEB-45EE-B1E8-9EA381471181</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Kananura</gtr:otherNames><gtr:surname>Tibenderana</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A6BAEC07-E057-4F0A-933A-BF3E851B5C99"><gtr:id>A6BAEC07-E057-4F0A-933A-BF3E851B5C99</gtr:id><gtr:firstName>Abdel</gtr:firstName><gtr:otherNames>Ghayoum</gtr:otherNames><gtr:surname>Babiker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/77BFBA36-5CEE-4975-8650-2C0A2EF6D4F7"><gtr:id>77BFBA36-5CEE-4975-8650-2C0A2EF6D4F7</gtr:id><gtr:firstName>Kathryn</gtr:firstName><gtr:surname>Maitland</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4034057C-40C9-4BA8-9CFC-5986FAC5B84C"><gtr:id>4034057C-40C9-4BA8-9CFC-5986FAC5B84C</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:otherNames>Margaret</gtr:otherNames><gtr:surname>Crawley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801439"><gtr:id>3DA93F8F-10A7-48DD-95E3-AB4B4098AB61</gtr:id><gtr:title>Randomised trial of fluid resuscitation strategies in African children with severe febrile illness &amp;amp; impaired perfusion</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801439</gtr:grantReference><gtr:abstractText>In hospitals throughout sub-Saharan Africa case fatality rates for severe infections in childhood remains at 15-30%. In this region well over a million children die of severe infection in hospital each year. Currently, antimalarial and antimicrobial drugs are the mainstay of treatment, however most deaths occur early, due to the complications of severe illness, and before definitive treatments have time to act. In this situation doctors have to rely upon supportive therapies to treat complications and try to improve outcome. Defining which are the best life saving treatments has been frustrated by the lack of clinical trials addressing this issue. 

Correction of fluid deficits by rapid infusion (volume expansion) is practised routinely for sick children presenting for emergency care and would be a logical supportive treatment for African children with severe illness and signs of impaired perfusion. Currently, reticence to adopt this approach remains and so most children are managed with little or no additional fluid. In these circumstances the method resolving uncertainty is though in a clinical trial.

FEAST is a multi centre study which aims to address this question and to definitively establish whether volume expansion with saline or albumin improves disability-free survival and whether this is best achieved by saline, a cheap a widely used solution or the more expensive colloid, albumin (a safe bi-product of a blood transfusion). 

If benefit were shown it could potentially save thousands of lives of young children annually. Preliminary analysis suggest that this represents a highly cost effective method for improving child survival and which could be easily adopted within future international guidelines for treating children with severe illness and signs of impaired perfusion.</gtr:abstractText><gtr:technicalSummary>In hospitals throughout sub-Saharan Africa (SSA) case fatality rates for severe infections in childhood remains at 15-30%. Curently, antimalarial and antimicrobial drugs are the mainstay of treatment, however most deaths occur early, due to the complications of severe illness, and before definitive treatments have time to act. In this situation doctors have to rely upon supportive therapies to treat complications and try to improve outcome. Defining which are the best life saving treatments has been frustrated by the lack of clinical trials addressing this issue. 

Correction of fluid deficits by rapid infusion (volume expansion) is practised routinely for sick children presenting for emergency care and would be a logical supportive treatment for children with severe illness with signs of impaired perfusion. Opinion of this perspective remains divided. Reticence to adopt this approach remains and thus in African hospitals children are managed with little fluid or no additional fluid or with blood transfusion despite the concerns over cost and long-term risk of infection. 

The FEAST trial is a large pragmatic randomised controlled trial in African children at 6 hospitals in SAA. It aims to address the question of whether the addition of fluid resuscitation to the standard case management to rapidly restore intravascular volume depletion of African children with severe febrile illness and clinical evidence of impaired perfusion is safe and results in improved survival compared to standard management alone. More specifically, the trial has been designed with the aim of resolving whether rapid correction of intravascular volume, using colloidal (albumin) or electrolyte solutions (saline), is safe and improves both survival and neurological outcome in children with severe falciparum malaria rather than the slow restoration of total body water deficits suggested by other clinical researchers and currently recommended in international guidelines. Most interventions will be given in the first two hours after admission. Children will be monitored for 48 hours. The primary endpoint is in-hospital mortality at 48 hours post randomisation. 

If benefit were shown it could potentially save thousands of lives of young children annually. An initial estimate of cost-effectiveness suggests that albumin would be cost-effective compared to no treatment for a decision maker willingness to pay $35 or $5.33 per life year gained. If albumin were superior to saline or standard of care then investment in translating the newer technologies to large regional blood transfusion services to produce a cheap, regional source of albumin would be necessary.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2608159</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mbale Regional Hospital</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Mbale and Soroti Hospitals- Wellcome Trust Collaboration</gtr:description><gtr:id>CE8A05FB-9A4F-4577-8A1D-010001A5CB0E</gtr:id><gtr:impact>Routine clinical surveillance is due to be introduced and already a number of sub studies of life threatening childhood infections within FEAST have provided collaborative links with the KEMRI Wellcome Trust Programme. These include studies of pathogenesis (immunology and pathogen biology groups), evaluation of community perceptions of the consent process developed for FEAST, case control genetic studies and new biomarkers for severe malaria. A number of these studies are being conducted by the PI from Mbale who is registered on KEMRI Open University PhD programme.</gtr:impact><gtr:partnerContribution>Development of a clinical research team and undertaken a number of substudies
A new laboratory will be built in the 2104, supported by Imperial College</gtr:partnerContribution><gtr:piContribution>These previously research na&amp;iuml;ve hospitals were brought into the FEAST trial by the PI working in parntership with Malaria Consortium, Uganda. The site PIs have worked with the FEAST team to develop a clinical research platform to study acute malaria, which remains the major cause of admission. Comparative studies with Kilifi offer new potential insights into disease pathogenesis.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:department>Malawi-Liverpool Wellcome Trust Clinical Research Programme</gtr:department><gtr:description>SMAART consortium</gtr:description><gtr:id>A044352A-654A-4B90-ABA4-06A37C43471A</gtr:id><gtr:impact>none yet; meeting planned for June 2016 to plan the grant submission to UK funder collaborative award</gtr:impact><gtr:partnerContribution>To overcome the barriers to achieving this goal, SMAART brings together applicants and co-investigators from three Wellcome Trust major overseas programmes (KEMRI Wellcome Trust Programme, Kenya, Malawi-Liverpool-Wellcome Trust Unit, Malawi (Prof David Lalloo) and Mahidol Oxford Research Unit, Thailand together with African scientists from existing or new collaborations and specialists in clinical trials ( MRC CTU at UCL) and ultimately national and international stakeholders. All are necessary to ensure that the most important questions are identified and combined optimally in the most efficient trial design which is acceptable and relevant to parents, healthcare professionals, ethical review boards and ministries of health. The network is thus a multi-disciplinary team providing complementary expertise and added value including links to other networks. The SMAART consortium encompasses decades of clinical and academic experience, track records of successful high quality research in low-income settings, and significant impact as evidenced by publication citation, grant funding and policy change.</gtr:partnerContribution><gtr:piContribution>The main aim of SMAART is to conduct better research studies faster, to improve outcomes from severe malaria. SMAART will act as the operational platform by which future research is planned in a coordinated and reciprocal manner to continuously update disease definitions and treatment guidelines for severe malaria.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>KEMRI-Wellcome Trust Research Programme</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>Genetic Haemoglobinopathy Group</gtr:department><gtr:description>Human Genetics</gtr:description><gtr:id>86561051-4F14-4E43-BAF4-BDD25334B6C8</gtr:id><gtr:impact>Laboratory strengthening at Mbale Regional Referral Hospital, Eastern Uganda
Multi-disciplinary: medical, immunology, molecular, genetics</gtr:impact><gtr:partnerContribution>Design of basic science investigation</gtr:partnerContribution><gtr:piContribution>Basic science investigation for FEAST trial and planned investigation in TRACT trial</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Medical Research Council Clinical Trials Unit</gtr:description><gtr:id>94B591A6-C7A2-42CB-8D29-8BCA728C12FB</gtr:id><gtr:impact>FEAST trial 
Publications 
Alexander Fleming Award
TRACT trial</gtr:impact><gtr:partnerContribution>Design of clinical trials, trial governance and data management, statatistical expertise

Multidisciplinary clinical trialists, infectious disease speacialists, health economists and specialists in health policy</gtr:partnerContribution><gtr:piContribution>Work leading up the trials, identification of partners, trial sites and design and execution of clinical trials</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:department>Mahidol University-Oxford Tropical Medicine Research Programme</gtr:department><gtr:description>SMAART consortium</gtr:description><gtr:id>5392580A-5D1D-4536-BEC0-E6CECAE6503C</gtr:id><gtr:impact>none yet; meeting planned for June 2016 to plan the grant submission to UK funder collaborative award</gtr:impact><gtr:partnerContribution>To overcome the barriers to achieving this goal, SMAART brings together applicants and co-investigators from three Wellcome Trust major overseas programmes (KEMRI Wellcome Trust Programme, Kenya, Malawi-Liverpool-Wellcome Trust Unit, Malawi (Prof David Lalloo) and Mahidol Oxford Research Unit, Thailand together with African scientists from existing or new collaborations and specialists in clinical trials ( MRC CTU at UCL) and ultimately national and international stakeholders. All are necessary to ensure that the most important questions are identified and combined optimally in the most efficient trial design which is acceptable and relevant to parents, healthcare professionals, ethical review boards and ministries of health. The network is thus a multi-disciplinary team providing complementary expertise and added value including links to other networks. The SMAART consortium encompasses decades of clinical and academic experience, track records of successful high quality research in low-income settings, and significant impact as evidenced by publication citation, grant funding and policy change.</gtr:partnerContribution><gtr:piContribution>The main aim of SMAART is to conduct better research studies faster, to improve outcomes from severe malaria. SMAART will act as the operational platform by which future research is planned in a coordinated and reciprocal manner to continuously update disease definitions and treatment guidelines for severe malaria.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>Medical Research Council Clinical Trials Unit</gtr:description><gtr:id>946CDC89-863D-4E54-9323-5765BCDE0CC3</gtr:id><gtr:impact>FEAST trial 
Publications 
Alexander Fleming Award
TRACT trial</gtr:impact><gtr:partnerContribution>Design of clinical trials, trial governance and data management, statatistical expertise

Multidisciplinary clinical trialists, infectious disease speacialists, health economists and specialists in health policy</gtr:partnerContribution><gtr:piContribution>Work leading up the trials, identification of partners, trial sites and design and execution of clinical trials</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Medicine Sans Frontiere</gtr:description><gtr:id>BB6155EA-1E39-4C84-BBA4-0658BB87185A</gtr:id><gtr:impact>Clinical studies on going in Kenya/Uganda

Multidisplinary: clinical trials, critical care, humanitarian health</gtr:impact><gtr:partnerContribution>Protocol development and cofunding for clinical trial</gtr:partnerContribution><gtr:piContribution>Design of fluid management studies in severe malnutrition</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Medical Research, Tanzania</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:department>Teule Hospital</gtr:department><gtr:description>NIMRI, Teule, Tanzania</gtr:description><gtr:id>2B183B76-C1BA-4198-81E5-0F90E7ABCFF8</gtr:id><gtr:impact>FEAST trial site</gtr:impact><gtr:partnerContribution>Teule Hospital, through NIMRI joined the FEAST trial</gtr:partnerContribution><gtr:piContribution>Relocation of FEAST to 5 new sites in East AFrica and resubmission of extension (GO801439) with coapplicants from NIMRI</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Malaria Consortium Africa, Kampala</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Malaria Consortium_ FEAST trial extension</gtr:description><gtr:id>2DBF33CC-75C4-4F3C-89D4-9369A5554DD5</gtr:id><gtr:impact>Extension of FEAST trial (G0801439)
Setting up of 3 new trial sties for research- required a multi disciplinary team.</gtr:impact><gtr:partnerContribution>Hosting of the FEAST management team and monitors. Financial and logistic management of 4 trial sites</gtr:partnerContribution><gtr:piContribution>THe FEAST trial was re-located from Ghana, The Gambia to Uganda and Teule, Tanzania. Linking to 4 sites in Uganda was made possible through a new collaboration with Malaria Consortium in partnership with our research team. Collaborators and co applicant added to extension (GO801439).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Mbale and Soroti Hospitals- Wellcome Trust Collaboration</gtr:description><gtr:id>A913DC20-2497-4517-955D-515C74C97C4A</gtr:id><gtr:impact>Routine clinical surveillance is due to be introduced and already a number of sub studies of life threatening childhood infections within FEAST have provided collaborative links with the KEMRI Wellcome Trust Programme. These include studies of pathogenesis (immunology and pathogen biology groups), evaluation of community perceptions of the consent process developed for FEAST, case control genetic studies and new biomarkers for severe malaria. A number of these studies are being conducted by the PI from Mbale who is registered on KEMRI Open University PhD programme.</gtr:impact><gtr:partnerContribution>Development of a clinical research team and undertaken a number of substudies
A new laboratory will be built in the 2104, supported by Imperial College</gtr:partnerContribution><gtr:piContribution>These previously research na&amp;iuml;ve hospitals were brought into the FEAST trial by the PI working in parntership with Malaria Consortium, Uganda. The site PIs have worked with the FEAST team to develop a clinical research platform to study acute malaria, which remains the major cause of admission. Comparative studies with Kilifi offer new potential insights into disease pathogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interviewed by Voice of America about NEJM Severe Malaria Perspective</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9CE97471-CE08-4202-B962-EEB6BBD7DC8B</gtr:id><gtr:impact>New England Journal Perspective on Severe Malaria in African Children: need for continuing investment. I discussed the slow pace of progress in clinical trials in Africa; yet 10% of children with severe malaria will die. In the drive to eliminate malaria most scientists and policy makers felt that malaria was all but conquered. Many expressed surprise at the burden of disease. Thought published only on 22nd December 2016 the current Altmetrics for this article is 124.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.voanews.com/a/death-toll-from-malaria-among-african-children-called-unacceptably-high/3665459.html</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio_Interview BBC</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BE56F866-D8EC-4727-A3FA-DEF62C0E0ACA</gtr:id><gtr:impact>In 2015 I was interviewed for BBC World Service Life Changers by Kevin Fong (Discovery-20150831-LifeChangersKathrynMaitland.mp3)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/programmes/p030mb5n</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medicine Sans Frontieres Fluid management Policy Review</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>719DCC76-4EB1-42C8-8EBD-D6AD45590361</gtr:id><gtr:impact>Heads of all the MSF programme met with representation from WHO to review fluid management guidelines following the publication of the FEAST trial.
Chair of FEAST TSC and Principal Investigator were invited to present data and discus whether guidelines should be changed

MSF have now changed their guidelines 
MSF commissioned a systematic review of fluid resuscitation which was published in PlosOne: http://www.ncbi.nlm.nih.gov/pubmed/22952819</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FEAST engagement with media over BMJ paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>10570579-A1D8-4841-BC9A-F496D935229E</gtr:id><gtr:impact>The story was covered by the Today Programme, BBC World Service, BBC News website, Guardian.

The World Health Organisation responded, saying they would release updated guidelines by the end of the year.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://www.ctu.mrc.ac.uk/news/2014/current_septic_shock_treatment_guidelines_are_putting_childrens_lives_at_risk_140114</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Anatomy of a clinical trial film</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>34CBC67B-E4A4-43BA-B176-E4B2E82D8FBB</gtr:id><gtr:impact>A film was developed, targeted at healthworkers, explaining the importance of clinical trials, using FEAST as an example. This film has been shown at a conference in South Africa, as well as being made available on YouTube and the MRC CTU website.

The film has had almost 500 views online. Health workers watching the film reported finding the interviews with the trial team before they found out the results, and watching them learn the results, to be very persuasive.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=GdMMuURsZQg&amp;list=UUxUK9Zn4Es5SxMbAYeTSO2g</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to WHO</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8A8D2E2F-02B3-4063-A612-E5DDB1B8479C</gtr:id><gtr:impact>WHO have the full results of trial (published and unpublished) as well as policy brief.
They are currently conducting a review of the evidence before the consider changing their guidelines

WHO are the key policy maker who advise on guidelines for management of children in LED countries including Africa. FEAST will direct inform policy 

WHO not yet changed policy further meeting with study investigators in 2012</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in The Economist and The independant</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C148DA82-EBCC-42B9-A6A2-54B138AF960A</gtr:id><gtr:impact>As a result of the press release I was contacted by journalists from the Economist magazine and The Independant newspaper. The FEAST trial was reported by Jonathan Ledgard for the Economist and Jeremy Lawrence for The Independant

Public recognistion that high quality trials can be conducted in Africa - with important results that will lead to policy changes.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting of African Paediatricians to review fluid resuscitation management policy fo</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0E3DF33B-0021-4A94-A453-BC8077B18A1E</gtr:id><gtr:impact>A meeting was held in Nairobi, 12th-13th October 2012, to examine the evidence on the use of boluses (rapid fluid resuscitation) for critically sick children in sub-Saharan Africa, and consider the implications of this evidence. The meeting was hosted by the Kenya Paediatric Association, and was attended by paediatricians and other healthcare personnel and researchers from 10 sub-Saharan African countries, as well as members of the FEAST trial team from Africa.

A meta-analysis of all the available evidence on fluid resuscitation for these children was carried out subsequently and has been published; it supports the conclusions of the FEAST trial (see http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043953).

This delegates agreed that the new evidence presented means that international and national guidelines, policy and practice need to change. The recommendations should no longer be that children with febrile illness (due to malaria and/or sepsis including presumptive diagnoses) and impaired perfusion, and/or impaired consciousness and/or respiratory distress should be given fluid boluses (ie giving fluids rapidly over a short period of time). Instead it should be recommended that maintenance fluids should be given slowly at 4ml/hour to replace fluid losses.

A number of hospitals (including those involved in the trial) and Medicins Sans Frontiers have already changed their practice in the light of these results, but other international and national organisations and institutions have been slower to change, due in part to lack of guidance from the World Health Organisation.

At the conclusion of the workshop the delegates indicated that it was clear to them from the published evidence and further discussions of evidence presented at the meeting that international (WHO) and national guidelines, policy and practice need to change.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043953</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Consultation: Nuffield Council on Bioethics</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F0B79524-2993-4D78-A155-B8F6858568A5</gtr:id><gtr:impact>I was asked to provide my views for Nuffield Council on Bioethics ahead of their consultation on ethical issues arising out of children's involvement in clinical research.

this has not yet happened</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Paediatrica Interview KAth Maitland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>74233BB2-F245-4686-BA2F-ED2017253C45</gtr:id><gtr:impact>I was invited to Boston Childrens Hospital to be filmed whilst interviewed on the World Shared Practice Forum on The FEAST trial. The forum has over 1000 members in 70 different countries. This went live late October 2013. It has an interactive tool where questions posed can be addressed

Global dissemination about FEAST trial paper and subsequent papers- to scientific and clinical audience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.openpediatrics.org/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Communication Strategy for stakeholders</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>62BF02F0-DBA7-4BCD-846E-F5E21FB26789</gtr:id><gtr:impact>Communication Strategy was developed for the main stakeholders - including health professionals, policy makers and public. Primarily designed to raise awareness of the existance and potential impact of the trial. 
In 2010 this was very active for non health professionals too.

Communities and hospitals were anxious to know the outcome of the study when published</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2747308</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Global Health Trials</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0801439</gtr:fundingRef><gtr:id>461D3BCF-9985-47B3-AF43-FF97FD6DC121</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Major Overseas Programme Grant</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>203077/Z/16/Z</gtr:fundingRef><gtr:id>383A61D1-6AF0-4213-BD6A-CCAB7C123BFA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>National Health and Medical Research Council (Australia)</gtr:department><gtr:description>Project Grant</gtr:description><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:fundingRef>APP1061382</gtr:fundingRef><gtr:id>F1E4005C-23FB-4584-9AE2-7725D48B37C5</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3252022</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Global Health Trials</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J012483/1</gtr:fundingRef><gtr:id>B3DB1939-E76D-4352-AF6B-49955BA09000</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alexander Flemming Dissemination Grant</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>C0395</gtr:fundingRef><gtr:id>79EC1CAF-1EDC-41D6-846D-CA3F05D3A570</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Consensus Round Table Symposium on Fluid resuscitation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E93AB37F-B76C-4FA6-BFC6-E6EEF1B5DC1D</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHOETAT: Management of Severe Illness in Resource-poor hospitals</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F2F628E5-2CF6-4F61-91BB-A321778C5A7B</gtr:id><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24462328</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Review of Resuscitation Fluids in NEJM</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>87AEE728-204E-45D0-A3AF-9E6DA966FD7B</gtr:id><gtr:type>Citation in clinical reviews</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24350966</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO 2014 severe malaria guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Severe Malaria</gtr:guidelineTitle><gtr:id>275DD26D-166A-4106-850F-2C42DB1C3B4A</gtr:id><gtr:impact>Fluid resuscitation is not longer recommended for children with severe malaria- leading to the saving of many lives worldwide.</gtr:impact><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/25214480</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Fluid resuscitation in children</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0578AD4F-AD8C-4F93-9131-54ABC040FF31</gtr:id><gtr:impact>Medicine Sans Frontieres commissioned this review and changed their treatment guidelines for fluid resuscitation in children</gtr:impact><gtr:type>Citation in systematic reviews</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/22952819</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Multiple Commentaries and Reviews of FEAST trial result</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>34D028D4-5533-41BF-98DF-BBFDF9366883</gtr:id><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Systematic Review of Fluid resuscitation in children</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E658E316-84AB-460E-BACC-7063BE686003</gtr:id><gtr:impact>Medicine Sans Frontiere changed guidelines</gtr:impact><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>East Africa Guidelines Panel Recommendations</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:guidelineTitle>Draft recommendations for management of children with severe febrile illness and impaired circulation without signs of severely impaired circulation</gtr:guidelineTitle><gtr:id>AD42E6A5-D70A-414E-AEC1-51FE9B670778</gtr:id><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MSF shock algorithms</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Management of circulatory failure in normally nourished children</gtr:guidelineTitle><gtr:id>05F68624-9F90-4BF2-AA54-1691D93A9A68</gtr:id><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of Technical Expert Group for Severe Malaria</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B53D3E69-CCDB-4938-9369-4B760079BC17</gtr:id><gtr:impact>Fluid management of severe malaria in children has been informed by the publication of the FESAT trial. The TEG is currently (Nov 2013) undertaking a revision of management guidelines (to be published in 2015). WHO will consider recommendation made by this review committee whilst revising current guidelines.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in 'A critique of fluid bolus resuscitation in severe sepsis'</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>04AF34D8-CDEB-410C-A450-80F62D3C82D6</gtr:id><gtr:type>Citation in clinical reviews</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/22277834</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influence on WHO Guideline on Paediatric emergency triage, assessment and treatment: Care of critically ill children</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>WHO Guideline on Paediatric emergency triage, assessment and treatment: Care of critically ill children</gtr:guidelineTitle><gtr:id>ACBEF4E0-2D33-4436-919E-FD17F34304FE</gtr:id><gtr:impact>The new WHO guidelines recommend that rapid fluid resuscitation is not used for children with 1 or 2 signs of shock, following the results of the FEAST trial. However, they still recommend (more conservative) fluid resuscitation for children with all three signs of shock.
FEAST found that rapid fluid resuscitation was associated with excess mortality for children with any definition of shock. The new guidelines are progress, but do not completely accord with the FEAST recommendations.</gtr:impact><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://apps.who.int/iris/bitstream/10665/204463/1/9789241510219_eng.pdf?ua=1</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Acute Dialysis Quality Initiative (ADQI) consensus conference Fluid management in critical illness</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>112C47ED-56B5-401B-9D35-C15FB2A2DADC</gtr:id><gtr:impact>The delegates of the 12th Acute Dialysis Quality Initiative (ADQI) Conference sought to obtain consensus on the use of i.v. fluids with the aim of producing guidance for their use. The reviewed a recently proposed model for fluid therapy in severe sepsis and propose a framework by which it could be adopted for use in most situations where fluid management is required. Considering the dose-effect relationship and side-effects of fluids, fluid therapy should be regarded similar to other drug therapy with specific indications and tailored recommendations for the type and dose of fluid. By emphasizing the necessity to individualize fluid therapy, we hope to reduce the risk to our patients and improve their outcome</gtr:impact><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/25204700</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Open Clinica was used a platform for this database</gtr:description><gtr:id>2A480AFE-12FF-43AA-BB92-870BFDC23ED7</gtr:id><gtr:impact>Multiple papers have resulted from this database, and has feed into chapters in at least 2 Phds. The database will eventually become open access</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>FEAST trial database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>FEAST is the largest Phase III paediatric fluid resuscitation trial ever undertaken. To ensure an ethical and humane process to approaching parents- we developed a novel strategy for deferred consent. We were uncomfortable with full consent waiver since this may mean that parents may never get to know that their child was involved in a research study - which if they had known at the time of admission they could have exercised their right to refuse. For the sickest children we opted for, and have ethical approval for, parental verbal assent, where parents understood that their child would be involved in a clinical trial, but the details would be given after recruitment - during informed consent- once their child was stablised. We plan substudies to evaluate this with social sciences groups specializing in research ethics. Our methodology has been written up and recently submitted for publication.</gtr:description><gtr:id>A5C14B28-1E8A-407D-90E1-301F6F94D43A</gtr:id><gtr:impact>The ethical landscape has changed so vastly such that any pragmatic consenting process giving the key sensitivities to parents so they can weigh up risks and benefits contextually is now a rare phenomenon. Having presented the FEAST trial at international paediatric critical care conferences and more recently in a meningitis meeting - our consent process was welcomed as practical and helpful example by paediatricians who are struggling with European ICH GCP legislation. There have been two important regulatory developments in recent years. Firstly, in January 2007 EU paediatric medicine regulation (Regulation (EC) No 1901/2006) requiring all new license applications to include paediatric data. Followed by the December 2006 amendment to the EU trials directive that was intended to enable research in emergencies. Recent reports suggest this is not working in practice. The new requirement for research in children is compounded by the lack of guidance for conducting studies in this setting. FEAST trial consent process therefore sets a benchmark for future paediatric trials.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Pragmatic Deferred Consent Proceedure for research in emergency medicine</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/23408950</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Open Clinica an open source database software that was specifically adapted for use in this trial by our programmer/data manager</gtr:description><gtr:id>DE508DCA-871D-4EFA-B3B3-1A2B32F52E3A</gtr:id><gtr:impact>Wider appreciation that open source software can be used as a platform for GCP trial and is compliant with FDA standards</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Development of Open Clinica for multisite trial</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/21453454</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/985D5390-DF9E-4AB4-866B-BA823B7F7273"><gtr:id>985D5390-DF9E-4AB4-866B-BA823B7F7273</gtr:id><gtr:title>Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) Score.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/384b04922ff8fd8e644428e3c4cd9d4b"><gtr:id>384b04922ff8fd8e644428e3c4cd9d4b</gtr:id><gtr:otherNames>George EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54C7CDE2-D0C5-4DDD-BB48-99F6493C2F4A"><gtr:id>54C7CDE2-D0C5-4DDD-BB48-99F6493C2F4A</gtr:id><gtr:title>Management of severe malaria: results from recent trials.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed5b3cb32e7e2511144de37caf6e2d66"><gtr:id>ed5b3cb32e7e2511144de37caf6e2d66</gtr:id><gtr:otherNames>Olupot-Olupot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A6632FEB-CFCE-43A6-97AD-A5F172B9F7BF"><gtr:id>A6632FEB-CFCE-43A6-97AD-A5F172B9F7BF</gtr:id><gtr:title>Hypoglycaemia in severe malaria, clinical associations and relationship to quinine dosage.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/edb3b941e3276e0397cdcea82bcd0d8b"><gtr:id>edb3b941e3276e0397cdcea82bcd0d8b</gtr:id><gtr:otherNames>Ogetii GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/612853AD-14AF-461A-9B3C-56EA7461B3B6"><gtr:id>612853AD-14AF-461A-9B3C-56EA7461B3B6</gtr:id><gtr:title>Strategies for efficient computation of the expected value of partial perfect information.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C65CB8CD-3D93-42B4-9DF7-A04D69D87A18"><gtr:id>C65CB8CD-3D93-42B4-9DF7-A04D69D87A18</gtr:id><gtr:title>Use of deferred consent for severely ill children in a multi-centre phase III trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86eb93149109bb11bc7f076a9c50c2ab"><gtr:id>86eb93149109bb11bc7f076a9c50c2ab</gtr:id><gtr:otherNames>Maitland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C86CD782-B2D4-4E34-B192-F857E92E465D"><gtr:id>C86CD782-B2D4-4E34-B192-F857E92E465D</gtr:id><gtr:title>Management of severe paediatric malaria in resource-limited settings.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86eb93149109bb11bc7f076a9c50c2ab"><gtr:id>86eb93149109bb11bc7f076a9c50c2ab</gtr:id><gtr:otherNames>Maitland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C7461590-027C-4B56-A7B4-0D1C870D2A36"><gtr:id>C7461590-027C-4B56-A7B4-0D1C870D2A36</gtr:id><gtr:title>Endotoxaemia is common in children with Plasmodium falciparum malaria.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed5b3cb32e7e2511144de37caf6e2d66"><gtr:id>ed5b3cb32e7e2511144de37caf6e2d66</gtr:id><gtr:otherNames>Olupot-Olupot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/400F7A50-3445-476F-9EBD-29ACD4475E43"><gtr:id>400F7A50-3445-476F-9EBD-29ACD4475E43</gtr:id><gtr:title>'The words will pass with the blowing wind': staff and parent views of the deferred consent process, with prior assent, used in an emergency fluids trial in two African hospitals.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ef4ca17df21fb85d5773d6b0068940b"><gtr:id>1ef4ca17df21fb85d5773d6b0068940b</gtr:id><gtr:otherNames>Molyneux S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5108D597-A9FD-4DE9-8673-D0BA08AB0D52"><gtr:id>5108D597-A9FD-4DE9-8673-D0BA08AB0D52</gtr:id><gtr:title>Authors' reply to Southall.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a95726c6f6fe2073a4b03b81f5d7def1"><gtr:id>a95726c6f6fe2073a4b03b81f5d7def1</gtr:id><gtr:otherNames>Kiguli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB24D952-F891-4740-AB2B-8A9999836D90"><gtr:id>FB24D952-F891-4740-AB2B-8A9999836D90</gtr:id><gtr:title>Choice of fluids for resuscitation in children with severe infection and shock: systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d3de0e37cf6cf2c6803b51eeb31bf14d"><gtr:id>d3de0e37cf6cf2c6803b51eeb31bf14d</gtr:id><gtr:otherNames>Akech S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B01384D9-A6A1-4D84-90D5-B5F4C9BAC6A4"><gtr:id>B01384D9-A6A1-4D84-90D5-B5F4C9BAC6A4</gtr:id><gtr:title>Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a95726c6f6fe2073a4b03b81f5d7def1"><gtr:id>a95726c6f6fe2073a4b03b81f5d7def1</gtr:id><gtr:otherNames>Kiguli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75FF55C6-DAE7-425B-AAAB-6C623B747E5D"><gtr:id>75FF55C6-DAE7-425B-AAAB-6C623B747E5D</gtr:id><gtr:title>Increased adhesion of Plasmodium falciparum infected erythrocytes to ICAM-1 in children with acute intestinal injury.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/58cbf2d787fb2976b27aae106b3e332d"><gtr:id>58cbf2d787fb2976b27aae106b3e332d</gtr:id><gtr:otherNames>Church JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8D229541-78D2-486F-A019-1029F8D82705"><gtr:id>8D229541-78D2-486F-A019-1029F8D82705</gtr:id><gtr:title>Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1df7879150f7e4c2c27b8113f37a9c85"><gtr:id>1df7879150f7e4c2c27b8113f37a9c85</gtr:id><gtr:otherNames>Mo?si JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/72E79D96-A5B6-4068-9F2F-91006C2324D0"><gtr:id>72E79D96-A5B6-4068-9F2F-91006C2324D0</gtr:id><gtr:title>Mortality after fluid bolus in African children with severe infection.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86eb93149109bb11bc7f076a9c50c2ab"><gtr:id>86eb93149109bb11bc7f076a9c50c2ab</gtr:id><gtr:otherNames>Maitland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BD1B867-92E3-4115-8053-4DA805B9530D"><gtr:id>3BD1B867-92E3-4115-8053-4DA805B9530D</gtr:id><gtr:title>Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86eb93149109bb11bc7f076a9c50c2ab"><gtr:id>86eb93149109bb11bc7f076a9c50c2ab</gtr:id><gtr:otherNames>Maitland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/044C985B-A6F3-43BF-BB9C-25DFC6C582B5"><gtr:id>044C985B-A6F3-43BF-BB9C-25DFC6C582B5</gtr:id><gtr:title>Management of severe malaria: results from recent trials.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed5b3cb32e7e2511144de37caf6e2d66"><gtr:id>ed5b3cb32e7e2511144de37caf6e2d66</gtr:id><gtr:otherNames>Olupot-Olupot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/898D44AD-056D-41B4-9197-4B30477A85A2"><gtr:id>898D44AD-056D-41B4-9197-4B30477A85A2</gtr:id><gtr:title>Choice of fluids for resuscitation in children with severe infection and shock: systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d3de0e37cf6cf2c6803b51eeb31bf14d"><gtr:id>d3de0e37cf6cf2c6803b51eeb31bf14d</gtr:id><gtr:otherNames>Akech S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40D4B5C9-73C3-40EC-AED3-0520E6AA9F9A"><gtr:id>40D4B5C9-73C3-40EC-AED3-0520E6AA9F9A</gtr:id><gtr:title>Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fedd129d241c35a3047bd96947e42660"><gtr:id>fedd129d241c35a3047bd96947e42660</gtr:id><gtr:otherNames>von Seidlein L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD558688-45F7-4A57-9B69-08FE85259163"><gtr:id>DD558688-45F7-4A57-9B69-08FE85259163</gtr:id><gtr:title>WHO guidelines on fluid resuscitation in children: missing the FEAST data.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a95726c6f6fe2073a4b03b81f5d7def1"><gtr:id>a95726c6f6fe2073a4b03b81f5d7def1</gtr:id><gtr:otherNames>Kiguli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB57D72D-5EDC-4EE6-9B99-E74FD1AEBE18"><gtr:id>DB57D72D-5EDC-4EE6-9B99-E74FD1AEBE18</gtr:id><gtr:title>Spleen volume and clinical disease manifestations of severe Plasmodium falciparum malaria in African children.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2ed462db019a220abcf6071792eff3ab"><gtr:id>2ed462db019a220abcf6071792eff3ab</gtr:id><gtr:otherNames>Kotlyar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90DF1D73-8EC6-45F3-A22B-E31B5E6BC1B6"><gtr:id>90DF1D73-8EC6-45F3-A22B-E31B5E6BC1B6</gtr:id><gtr:title>Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a95726c6f6fe2073a4b03b81f5d7def1"><gtr:id>a95726c6f6fe2073a4b03b81f5d7def1</gtr:id><gtr:otherNames>Kiguli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF247D04-78CF-450C-AC3C-9AEAEB7ACBBB"><gtr:id>EF247D04-78CF-450C-AC3C-9AEAEB7ACBBB</gtr:id><gtr:title>Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemia.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed5b3cb32e7e2511144de37caf6e2d66"><gtr:id>ed5b3cb32e7e2511144de37caf6e2d66</gtr:id><gtr:otherNames>Olupot-Olupot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/036A6F54-DE13-439A-B9AD-AE3582C45725"><gtr:id>036A6F54-DE13-439A-B9AD-AE3582C45725</gtr:id><gtr:title>When enough is enough: how the decision was made to stop the FEAST trial: data and safety monitoring in an African trial of Fluid Expansion As Supportive Therapy (FEAST) for critically ill children.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5d32ae8ae3b66f93705d522ade5c3a28"><gtr:id>5d32ae8ae3b66f93705d522ade5c3a28</gtr:id><gtr:otherNames>Todd J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801439</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>